Reproductive endocrinology

From concept to protocol: iterative approach of a target trial emulation on GnRH analog safety in transgender and gender diverse youth

Eur J EndocrinolPublished Methodological study

Authors' conclusion

This discussion paper serves as a methodological example of target trial emulation with observational data to study long-term safety of GnRHa in TGDA. By transparently addressing methodological challenges and incorporating expert input, this approach offers a feasible and ethically sound alternative to RCTs, and contributes to the evidence base needed for informed clinical and policy decisions in transgender healthcare.

Study context

Population
Transgender and gender diverse adolescents (TGDAs), observational data from national healthcare registries
Exposure
Gonadotropin-releasing hormone analog (GnRHa) treatment vs late-presenting TGDA individuals
Outcome
Long-term safety of GnRHa treatment
Methodological detailstarget trial emulation protocol, national healthcare registries, expert review, Independent experts in causal inference reviewed the concept design; feedback systematically summarized and discussed
  • Target trial emulation protocol
  • National healthcare registries
  • Expert review
  • Independent experts in causal inference reviewed the concept design; feedback systematically summarized and discussed

Main finding

As reported in the abstract

Study design
  • Main methodological challenges: selection of the control group and definition of time zero
  • Design will select late-presenting TGDA individuals as control group; time zero is GnRHa initiation in the intervention group and the equivalent age in controls
  • Sensitivity analyses with alternative control groups and time zero definitions will assess robustness

Observational data: associations, not effects.

Original publication

From concept to protocol: iterative approach of a target trial emulation on GnRH analog safety in transgender and gender diverse youth. Eur J Endocrinol. Published 17 June 2026. doi:10.1093/ejendo/lvag105

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.